QUINAGOLIDE VAGINAL RING FOR ENDOMETRIOSIS: RESULTS FROM THE CLINICAL PHASE 1 PROGRAM
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This Phase 1 program evaluated the safety, tolerability, and pharmacokinetics of a quinagolide vaginal ring in healthy women to assess its potential for endometriosis treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials 2022
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
Cited by (3)
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials 2022
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-16T06:28:21.314993+00:00
License: CC0
· commercial use OK